CDC107: A Protein with Potential as A Drug Target Or Biomarker

Target Name: CCDC107

NCBI ID: G203260

CDC107: A Protein with Potential as A Drug Target Or Biomarker

CCDC107 (CCDC107 variant A) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the C-type water-type transmembrane protein (TMP) family, which is characterized by the presence of a transmembrane domain and a N-terminus that is involved in protein-protein interactions.

One of the unique features of CCDC107 is its ability to interact with several different proteins, including the protein known as PDGF-BB (Platelet-derived growth factor-beta). This interaction between CCDC107 and PDGF-BB has been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival.

In addition to its interaction with PDGF-BB, CCDC107 has also been shown to interact with several other proteins, including the protein known as NF-kappa-B1 (nuclear factor-kB1). This interaction between CCDC107 and NF-kappa-B1 has been shown to play a role in the regulation of cellular processes such as inflammation, pain, and stress.

The unique combination of interactions between CCDC107 and PDGF-BB, as well as its interaction with NF-kappa-B1, makes it an attractive potential drug target. Researchers are currently working to develop small molecules that can specifically interact with CCDC107 and enhance its ability to interact with PDGF-BB and NF-kappa-B1. These small molecules may be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, CCDC107 is also being studied as a biomarker for several diseases. For example, CCDC107 has been shown to be elevated in the blood of individuals with pancreatic cancer, and may be used as a diagnostic marker for this disease. Additionally, CCDC107 has been shown to be elevated in the urine of individuals with neurodegenerative diseases, and may be used as a diagnostic marker for these conditions.

Overall, CCDC107 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Coiled-coil Domain Containing 107

More Common Targets